Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13
A Variant of Leptin Gene Decreases the Risk of Gastric Cancer in Chinese Individuals: Evidence from a Case–Control Study [Corrigendum]
Received 5 October 2020
Accepted for publication 5 October 2020
Published 14 October 2020 Volume 2020:13 Pages 485—486
Ma R, He Q. Pharmgenomics Pers Med. 2020;13:397–404.
The authors have advised the affiliation list on page 397 is incorrect. The correct author list and affiliation is as follows.
Renjie Ma1
Qi He2
1Department of General Surgery, The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, 212300, Jiangsu Province, China; 2Department of Infectious Disease, The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, 212300, Jiangsu Province, China
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.